This consortium is part of the partnership dynamic that we initiated in November 2020 with the Auvergne-Rhône-Alpes Region, the Lyonbiopôle competitiveness cluster and the company VirHealth by implementing the first studies in Europe to evaluate in a test chamber the performance of several air treatment devices in an atmosphere contaminated by the infectious SARS-CoV-2 virus. On the basis of the experimental results obtained and previous technical knowledge of these devices, the Auvergne-Rhône-Alpes Region had released a budget of 10 million euros to install 2,500 air purifiers in 285 high schools and 189 municipalities in the territory to strengthen measures limiting the spread of the SARS-CoV-2 virus in the population.

We are proud to contribute with our partners VirexpR, CONIDIA CONIPHY and IMeBIO of the GESPPAIR consortium, the TERA Group and the companies ASPIDA and AIRXOM to a better control of emerging and re-emerging respiratory viral pathogens and more globally to a better IAQ of confined environments. This GESPPAIR alliance also illustrates our intention to create technological, economic and societal values in the Auvergne-Rhône-Alpes region and to contribute to the development of French industries and their international competitiveness.